Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06590220

Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy

Establishment of Multiparametric Prediction Models for Moderate to Severe Thyroid Associated Ophthalmopathy

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Shanghai Changzheng Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Thyroid-associated ophthalmopathy (TAO) is an organ-specific autoimmune disease closely related to thyroid disease, which leads the incidence of orbital disease in adults and is the most common cause of diffuse toxic goiter (Graves disease, GD). The clinical manifestations of TAO are complex and varied. In severe cases, it may seriously impair visual function, affect daily life, and even cause corneal ulceration, perforation, and blindness. Therefore, a reasonable and effective treatment plan should be chosen according to the degree of TAO. The aim of this clinical study is to: 1. Found the new diagnostic markers or imaging sequences. 2. Establish and validate a multimodal and multiparameter prediction model for moderate to severe TAO.

Conditions

Timeline

Start date
2024-10-09
Primary completion
2026-09-06
Completion
2028-09-06
First posted
2024-09-19
Last updated
2025-06-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06590220. Inclusion in this directory is not an endorsement.

Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy (NCT06590220) · Clinical Trials Directory